Statin use appears to reduce risk of serious bacterial bloodstream infection

October 2, 2017, Elsevier
Blood culture plate showing growth of S. aureus. Credit: Jesper Smit, MD, PhD

Users of statins, widely prescribed for prevention of cardiac disease, have a 27% lower risk of contracting a Staphylococcus aureus (S. aureus) bloodstream infection outside of a hospital, according to a new study in Mayo Clinic Proceedings. Researchers report that statin use, especially among elderly patients with preexisting chronic conditions such as diabetes, kidney, or liver disease, may be protective against this serious bloodstream infection. As the western world's population is aging and more people live with chronic medical conditions, any potential preventive effect of statins could have important clinical implications.

To investigate whether individuals treated with statins experienced a decreased risk of by S. aureus, researchers from the University Hospitals in Aalborg and Aarhus, Denmark and the University Hospital in Seville, Spain analyzed records of close to 30,000 people using Danish medical registries over a 12-year period. They identified 2,638 cases of community-acquired S. aureus bacteremia (CA-SAB). An additional 26,379 individuals were matched by age, sex, and residence against the cases. For the CA-SAB cases and the controls, 368 (14.0%) and 3,221 (12.2%), respectively, were current users of medications.

The team also investigated the risk of while taking into account the duration of current or former statin use, 90-day cumulative dose, and specific sub-groups of patients who were prescribed statins for different like previous myocardial infarction, peripheral arterial disease, chronic heart failure, , and diabetes.

Investigators found that the risk for CA-SAB decreased gradually with increasing statin dosage, and the association was most pronounced among patients with chronic kidney disease and diabetes. Current users of statins experienced a 27% decrease in risk for CA-SAB and long-terms users (multiple prescriptions across more than 90 days) had a 30% decrease, while new users (first prescription within 90 days) showed a modest 4% decrease in risk.

"Our results indicate that statins may have an important place in the prevention of bloodstream infection caused by S. aureus, which would hold important clinical and public health implications. Nevertheless, our observations warrant confirmation in other settings and the biological mechanisms by which statin treatment may protect against this type of infection should be explored further," explained lead investigator Jesper Smit, MD, PhD, of the Department of Clinical Microbiology, Department of Infectious Diseases, Aalborg University Hospital, and Department of Clinical Epidemiology, Aarhus University Hospital, Denmark.

In an accompanying editorial, Daniel C. DeSimone, MD, of the Division of Infectious Diseases, and Christopher V. DeSimone, MD, PhD, of the Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, expand on the importance of the study's findings and provide additional insights with more details about S. aureus infections and statin pharmacology, and put these findings into clinical context. The authors comment, "The work by Smit et al raises the exciting possibility that the pleiotropic effects of statins may also harbor important antimicrobial effects that may exert a clinically relevant benefit by conferring resistance to CA-SAB." They also state that "This persuasive study should stimulate randomized, placebo-controlled trials examining this effect of statins. Such trials in the case of statins are appealing because these drugs are relatively low cost, can easily be matched against a placebo, and would allow for enrollment at the time of an already necessary antibiotic prescription." This accompanying editorial provides exciting avenues for future human clinical trials to test statin drugs for disease prevention, especially in the field of cardiovascular infections.

S. aureus is a bacterium that can colonize skin. It has the propensity to cause serious infection which can be fatal if the bacteria disperse into the bloodstream. Statins are among the most widely used drugs for prevention of cardiovascular , but there have been some studies that suggest a link to an antimicrobial effect against S. aureus. Statins may also inhibit host cell invasion by S. aureus and enhance the ability of phagocytes to kill the bacterium.

Explore further: Use of glucocorticoids is associated with increased risk of serious bacterial blood infection

More information: Jesper Smit et al, Statin Use and Risk of Community-Acquired Staphylococcus aureus Bacteremia, Mayo Clinic Proceedings (2017). DOI: 10.1016/j.mayocp.2017.07.008

Daniel C. DeSimone et al. Beyond Vasoprotection: Statins and Risk Reduction for Community-Acquired Staphylococcus aureus Bacteremia, Mayo Clinic Proceedings (2017). DOI: 10.1016/j.mayocp.2017.08.013

Related Stories

Use of glucocorticoids is associated with increased risk of serious bacterial blood infection

June 8, 2016
The risk of life-threatening blood infections by Staphylococcus aureus bacteria is more than doubled in users of systemic glucocorticoids compared with non-users. The risk escalates with increasing dose, according to a new ...

Newly diagnosed diabetes increases risk of heart attack, stroke even among statin users

May 18, 2016
Postmenopausal women with newly diagnosed diabetes have a significantly increased risk of atherosclerotic cardiovascular disease whether or not they take statin drugs, according to the results of a new study led by researchers ...

Use of statins before cardiac arrest may aid survival afterwards

November 12, 2016
Patients who have been taking statins are likely to survive longer after a cardiac arrest than those who are not taking them, according to research from Taiwan researchers presented during the Resuscitation Science Symposium ...

Are cholesterol-lowering statins associated with reduced Alzheimer risk?

December 12, 2016
An analysis of Medicare data suggests that high use of cholesterol-lowering statins was associated with a reduced risk for Alzheimer disease but that reduction in risk varied by type of statin and race/ethnicity, findings ...

Statin drugs reduce infection risk in stroke patients

June 16, 2016
A Washington State University researcher has found that statin drugs can dramatically lower the risk of infections in stroke patients.

Recommended for you

A Trojan Horse delivery for treating a rare, potentially deadly, blood-clotting disorder

September 21, 2018
In proof-of-concept experiments, University of Alabama at Birmingham researchers have highlighted a potential therapy for a rare but potentially deadly blood-clotting disorder, TTP. The researchers deliver this therapeutic ...

Japanese team creates human oogonia using human stem cells in artificial mouse ovaries

September 21, 2018
A team of researchers with members from several institutions in Japan has successfully generated human oogonia inside of artificial mouse ovaries using human stem cells. In their paper published in the journal Science, the ...

Researchers explore how changes in diet alter microbiome in artificial intestine

September 21, 2018
Using an artificial intestine they created, researchers have shown that the microbiome can quickly adapt from the bacterial equivalent of a typical western diet to one composed exclusively of dietary fats. That adaptation ...

A new approach to developing a vaccine against vivax malaria

September 21, 2018
A novel study reports an innovative approach for developing a vaccine against Plasmodium vivax, the most prevalent human malaria parasite outside sub-Saharan Africa. The study led by Hernando A. del Portillo and Carmen Fernandez-Becerra, ...

Study identifies stem cell that gives rise to new bone and cartilage in humans

September 20, 2018
A decade-long effort led by Stanford University School of Medicine scientists has been rewarded with the identification of the human skeletal stem cell.

Scientists grow human esophagus in lab

September 20, 2018
Scientists working to bioengineer the entire human gastrointestinal system in a laboratory now report using pluripotent stem cells to grow human esophageal organoids.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.